Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8618076 Nucleoside phosphoramidates

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 31, 2011
Date of Patent
December 31, 2013
Patent Application Number
13076552
Patent Citations Received
‌
US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
0
‌
US Patent 11707479 Combination formulation of two antiviral compounds
0
‌
US Patent 11975016 2′-substituted-N
0
‌
US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
0
‌
US Patent 11707480 Highly active compounds against COVID-19
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8618076
Patent Primary Examiner
‌
Eric S Olson

Find more entities like US Patent 8618076 Nucleoside phosphoramidates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.